X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (273) 273
index medicus (191) 191
female (186) 186
male (182) 182
oncology (171) 171
middle aged (161) 161
aged (138) 138
adult (118) 118
lung neoplasms - drug therapy (91) 91
lung neoplasms - pathology (74) 74
chemotherapy (71) 71
carcinoma, non-small-cell lung - drug therapy (69) 69
respiratory system (67) 67
carcinoma, non-small-cell lung - pathology (64) 64
cancer (60) 60
neoplasm staging (55) 55
lung cancer (52) 52
treatment outcome (50) 50
antineoplastic combined chemotherapy protocols - therapeutic use (48) 48
hematology, oncology and palliative medicine (46) 46
lung cancer, non-small cell (45) 45
aged, 80 and over (42) 42
lung neoplasms - genetics (41) 41
prognosis (38) 38
non-small cell lung cancer (36) 36
carcinoma, non-small-cell lung - mortality (35) 35
research (35) 35
lung neoplasms - mortality (33) 33
carcinoma, non-small-cell lung - genetics (31) 31
analysis (30) 30
retrospective studies (29) 29
survival (29) 29
trial (29) 29
radiology, nuclear medicine & medical imaging (28) 28
surgery (28) 28
therapy (28) 28
mutation (27) 27
radiotherapy (27) 27
tumors (27) 27
cell lung-cancer (26) 26
erlotinib (26) 26
nsclc (26) 26
positron-emission-tomography (26) 26
pulmonary/respiratory (26) 26
carcinoma (25) 25
care and treatment (25) 25
lung neoplasms - therapy (24) 24
netherlands (24) 24
carcinoma, non-small-cell lung - therapy (23) 23
cisplatin (23) 23
receptor, epidermal growth factor - genetics (23) 23
antineoplastic agents - therapeutic use (22) 22
lung neoplasms - surgery (22) 22
follow-up studies (21) 21
lung neoplasms - diagnostic imaging (21) 21
non-small-cell lung cancer (21) 21
respiratory tract diseases (21) 21
antineoplastic combined chemotherapy protocols - adverse effects (20) 20
disease-free survival (20) 20
docetaxel (20) 20
medicine & public health (20) 20
prospective studies (20) 20
erlotinib hydrochloride (19) 19
gefitinib (19) 19
lung neoplasms - diagnosis (19) 19
animals (18) 18
article (18) 18
carboplatin - administration & dosage (18) 18
carcinoma, non-small-cell lung - diagnostic imaging (18) 18
combined modality therapy (18) 18
mortality (18) 18
pet (18) 18
risk factors (18) 18
carboplatin (17) 17
carcinoma, non-small-cell lung - surgery (17) 17
cohort studies (17) 17
expression (17) 17
health aspects (17) 17
lung neoplasms - metabolism (17) 17
risk (17) 17
adolescent (16) 16
carcinoma, small cell - drug therapy (16) 16
cisplatin - administration & dosage (16) 16
kaplan-meier estimate (16) 16
lung-cancer (16) 16
patients (16) 16
time factors (16) 16
deoxycytidine - analogs & derivatives (15) 15
diagnosis (15) 15
genetic aspects (15) 15
growth-factor receptor (15) 15
phase-ii (15) 15
positron emission tomography (15) 15
positron-emission tomography (15) 15
reproducibility of results (15) 15
survival rate (15) 15
etoposide - administration & dosage (14) 14
oncology, experimental (14) 14
quality of life (14) 14
receptor, epidermal growth factor - antagonists & inhibitors (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 09/2014, Volume 25, Issue suppl_4, pp. iv23 - iv23
Abstract Introduction: The majority of molecular selected patients treated with targeted agents will eventually relapse due to incomplete target suppression,... 
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 1, pp. 348 - 353
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 85, Issue 1, pp. 19 - 24
Abstract Aim Non-small cell lung cancer (NSCLC)-patients with an epidermal growth factor receptor ( EGFR )-mutation have median progression-free survival (PFS)... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | EGFR mutation | T790M-mutation | NSCLC | Targeted therapy | Rebiopsy | TKI-resistance | TRANSFORMATION | NONSMALL CELL | GEFITINIB | MECHANISM | ADENOCARCINOMA | ACQUIRED-RESISTANCE | DRUG-RESISTANCE | CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | ONCOLOGY | RESPIRATORY SYSTEM | KRAS | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Mutation, Missense | Molecular Targeted Therapy | Incidence | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Retrospective Studies | Lung Neoplasms - genetics | Lung - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - diagnosis | Biopsy | Protein Kinase Inhibitors - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Adenocarcinoma - mortality | Lung cancer, Non-small cell | Genetic aspects
Journal Article
Lung Cancer, ISSN 0169-5002, 2013, Volume 80, Issue 1, pp. 102 - 105
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 8, pp. 1475 - 1484
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 70, Issue 3, pp. 685 - 692
Journal Article
Nature Genetics, ISSN 1061-4036, 2012, Volume 44, Issue 10, pp. 1104 - 1110